[Archived] 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Webinar

This is the 1st webinar in a 2-part series. To view this second presentation, click Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines: Caveats and Controversies.

75-Minute Webinar
Originally aired November 4, 2016

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

This 90-minute webinar introduces the 2016 Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis and highlight the development process, the key changes in recommendations, and discuss the evidence supporting the changes. The didactic presentations will be followed by a discussion period with the ATS, CDC, and IDSA guidelines co-chairs.

*CME and CE units are not being offered for this recording and there is no participant evaluation.

The training materials, including PDF handouts of the PowerPoint slides, are located here.

This training was recorded by Southeastern National Tuberculosis Center. 

Faculty:

Payam Nahid, MD, MPH
Guidelines co-chair, ATS
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
University of California, San Francisco
San Francisco, CA

Dick Menzies, MD
Professor of Medicine, and of Epidemiology & Biostatistics
Montreal Chest Clinic
McGill University
Montreal, Quebec, Canada

Facilitator:

Lisa Chen, MD
Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Medical Director/Principal Investigator
Curry International Tuberculosis Center (CITC)
University of California, San Francisco
San Francisco, CA

Panelists:

David Ashkin, MD, FCCP
Clinical Professor
University of Florida
Medical Director
Southeastern National Tuberculosis Center (SNTC)
TB Controller
Division of Disease Control and Health Protection
Florida Department of Health
Gainesville, FL

Andrew Vernon, MD, MHS
Guidelines co-chair, CDC
Chief
Clinical Research Branch
Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
Atlanta, GA

Susan E. Dorman, MD
Guidelines co-chair, IDSA
Professor of Medicine and International Health
Johns Hopkins University School of Medicine
Baltimore, MD